发明名称 |
COMBINATION THERAPY FOR COPD |
摘要 |
THE INVENTION CONCERNS AN AEROSOL FORMULATION SUITABLE FOR ADMINISTERING TO COPD PATIENTS BY MEANS OF A PRESSURIZED METERED DOSE INHALER (PMDI), COMPRISING GLYCOPYRRONIUM BROMIDE IN COMBINATION WITH FORMOTEROL. THE FORMULATION FURTHER COMPRISES A HFA PROPELLANT, A CO-SOLVENT, AND AN AMOUNT OF INORGANIC ACID SUFFICIENT TO STABILIZE BOTH THE GLYCOPYRRONIUM BROMIDE AND THE FORMOTEROL COMPONENTS. OPTIONALLY THE FORMULATION FURTHER COMPRISES BECLOMETASONE DIPROPIONATE. |
申请公布号 |
MY156949(A) |
申请公布日期 |
2016.04.15 |
申请号 |
MY2012PI02844 |
申请日期 |
2010.12.22 |
申请人 |
CHIESI FARMACEUTICI S.P.A. |
发明人 |
BONELLI,SAURO;USBERTI,FRANCESCA;ZAMBELLI,ENRICO |
分类号 |
A61K31/167 |
主分类号 |
A61K31/167 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|